ZURICH/BERLIN, July 28 (Reuters) - Here are some of the main
factors that may affect Swiss stocks on Wednesday:
COMPANY STATEMENTS
* Novartis NOVN.S says it receives FDA orphan drug
designation for NIS793 in pancreatic cancer NOVN.S
* Landis+Gyr Group AG LANDI.S : wins tender award by
Belgian Fluvius to supply smart meters and related services
LANDI.S
* Credit Suisse CSGN.S is expected to publish details of
its Archegos failures, the Wall Street Journals said. CSGN.S
ANALYSTS' VIEWS
IDORSIA LTD IDIA.S : JP MORGAN RAISES TARGET PRICE TO CHF
29 FROM CHF 28
INA INVEST HOLDING AG INAI.S : CREDIT SUISSE CUTS TARGET
PRICE TO CHF 22 FROM CHF 22.40
LONZA GROUP AG LONN.S : CREDIT SUISSE RAISES TARGET PRICE
TO CHF 750 FROM CHF 670
LOGITECH INTERNATIONAL SA LOGN.S : CREDIT SUISSE RAISES
TARGET PRICE TO CHF 139 FROM CHF 133
GURIT HOLDING AG GUR.S : BAADER HELVEA CUTS TARGET PRICE TO
CHF 2,234 FROM CHF 2,750
NOVARTIS AG NOVN.S : JP MORGAN RAISES TARGET PRICE TO CHF
84 FROM CHF 80
ABB LTD ABBN.S : CREDIT SUISSE RAISES TARGET PRICE TO CHF
32 FROM CHF 29
ECONOMY
Swiss July investor sentiment due at 0800 GMT
(Reporting by Zurich newsroom and Berlin Speed Desk)
((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))
((For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g
FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German .SDE
All SMI constituent stocks 0#.SSMI
DJ STOXX index .STOXX
Top 10 STOXX sectors .PGL.STOXXS
Top 10 EUROSTOXX sectors .PGL.STOXXES
Swiss mid-cap index .SSMI
Swiss all-share index .SSHI
Swiss market digest .AD.S
Sector overview CH/SECTOR1
All Swiss news CH
Swiss research news CH-RCH
All equity news E
SPEED GUIDES: EQUITY EQUITY/NEWS1 EUR/EQUITY SWITZERLAND REUTERS ))